UnitedHealth Group Incorporated (UNH)
UnitedHealth Group: It's Time To Be Greedy While The Market Panics
Avoid stocks priced for 'best case scenario'; seek those priced for 'worst case scenario' for potential substantial upside, like UNH. UNH's 25% decline due to temporary issues presents a buying opportunity with strong long-term earnings growth and high dividend yield. UNH's fundamentals remain strong despite recent setbacks; management projects a return to 13-16% earnings growth and high dividend growth.
UnitedHealth Group: Mr. Market Has Got It All Wrong
UnitedHealth's stock tanked following the Q1 earnings report after the company revised the earnings guidance for this year. Upon closer evaluation, it is evident that the challenges faced by the company are likely to be short-lived. The company is cheaply valued from a historical perspective, which does not make a lot of sense given strong growth expectations for the next five years.
Wall Street Shaken as UnitedHealth Tanks Since Q1 Miss: Buy the Dip?
From a valuation perspective, UNH appears expensive compared to its peers despite the drop in price.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UnitedHealth spent $1.7 million on executive security
UnitedHealth Group spent nearly $1.7 million on security for its top executives in 2024, the healthcare conglomerate disclosed on Monday, months after the fatal shooting of senior executive Brian Thompson outside a Manhattan hotel in December.
UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels
UnitedHealth Group Inc. NYSE: UNH is a bellwether for the health insurance industry. The company symbolized the flaws in managed care organizations (MCOs) in the medical sector after its United Healthcare CEO was assassinated in December 2024.
UnitedHealth spent $1.7 million on executive security in 2024, filing shows
UnitedHealth Group spent nearly $1.7 million on security for its top executives in 2024, the healthcare conglomerate disclosed on Monday, months after the fatal shooting of senior executive Brian Thompson outside a Manhattan hotel in December.
UnitedHealth Group: Not A Falling Knife
UnitedHealth Group's management team is the best-in-class. The data proves it. Current operational, financial and regulatory challenges represent near-term issues versus long-term industry fundamental deterioration. Despite rhetoric otherwise, the large health insurers remain the only viable game in town. The stock post-earnings valuation appears attractive. In one day, Mr. Market knocked about $120 billion off the market cap. My updated FVE is ~$525 versus a current ~$435 bid.
UNH Crashes Post Q1 Earnings: Should You Buy the Dip With ETFs?
UnitedHealth's worst drop in 25 years following dismal earnings presents an opportunity for investors to buy the stock with ETFs.
UnitedHealth Stock Heads for Worst Two-Day Stretch in 27 Years
UnitedHealth's latest earnings miss was almost entirely due to Medicare Advantage trends, analysts say.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
One Of The Worst Days In The UnitedHealth History, But That Can Be An Opportunity
UnitedHealth's recent stock drop is an overreaction to Q1 2025 earnings and outlook, presenting a strategic long-term buying opportunity. UNH's strong financials, including increased net income, free cash flow, and dividends, support its resilience and growth potential. Despite negative sentiment and market risks, historical data shows UNH's consistent recovery and higher trading levels after significant drops.
